A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 47/48 (2006.01) A61P 35/00 (2006.01) C07K 14/415 (2006.01) C07K 14/525 (2006.01) C07K 19/00 (2006.01)
Patent
CA 2595904
The present invention regards targeted BLyS polypeptides capable of binding to BLyS receptors and that deliver a cytotoxic agent, such as a cytotoxic peptide, for example. In particular aspects, the cytotoxic agent comprises at least part of rGelonin. These compositions are useful for treating, preventing, and/or monitoring therapy for a B-cell proliferative disorder.
La présente invention concerne des polypeptides BLyS ciblés qui peuvent se lier à des récepteurs de BLyS et qui délivrent un agent cytotoxique, par exemple, un peptide cytotoxique. Selon des aspects particuliers, l'agent cytotoxique comprend au moins une partie de of rGelonine. Ces compositions permettent de traiter, de prévenir et/ou de surveiller le traitement d'un trouble prolifératif des lymphocytes B.
Cheung Lawrence
Lyu Mi-Ae
Rosenblum Michael G.
Borden Ladner Gervais Llp
Research Development Foundation
LandOfFree
Blys fusion proteins for targeting blys receptor and methods... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Blys fusion proteins for targeting blys receptor and methods..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Blys fusion proteins for targeting blys receptor and methods... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1732092